首页 > 最新文献

Bjog-An International Journal of Obstetrics and Gynaecology最新文献

英文 中文
Enhanced Recovery After Gynaecological Surgery: Insights and Future Directions. 加强妇科手术后的恢复:见解与未来方向。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-19 DOI: 10.1111/1471-0528.18012
Jiayu Yan, Bilan Li
{"title":"Enhanced Recovery After Gynaecological Surgery: Insights and Future Directions.","authors":"Jiayu Yan, Bilan Li","doi":"10.1111/1471-0528.18012","DOIUrl":"10.1111/1471-0528.18012","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Necessity Is the Mother of Invention'-The Wider Significance of Novel Mid-Urethral Rectus Fascial Sling. 必要性是发明之母"--新型尿道中段直肌筋膜绑带的广泛意义。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-19 DOI: 10.1111/1471-0528.18015
Peter Emanuel Petros
{"title":"'Necessity Is the Mother of Invention'-The Wider Significance of Novel Mid-Urethral Rectus Fascial Sling.","authors":"Peter Emanuel Petros","doi":"10.1111/1471-0528.18015","DOIUrl":"10.1111/1471-0528.18015","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Position Modification Devices to Prevent Supine Sleep During Pregnancy. 防止孕期仰卧的体位调整装置。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-18 DOI: 10.1111/1471-0528.18019
Allan J Kember, Jane Warland, Sebastian R Hobson, Kuan Liu, Jerry Coleman
{"title":"Position Modification Devices to Prevent Supine Sleep During Pregnancy.","authors":"Allan J Kember, Jane Warland, Sebastian R Hobson, Kuan Liu, Jerry Coleman","doi":"10.1111/1471-0528.18019","DOIUrl":"https://doi.org/10.1111/1471-0528.18019","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to Healthy Prepregnancy Lifestyle and Risk of Adverse Pregnancy Outcomes: A Prospective Cohort Study. 坚持健康的孕前生活方式与不良妊娠结局的风险:前瞻性队列研究
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-18 DOI: 10.1111/1471-0528.17994
Hitomi Okubo, Shoji F Nakayama, Asako Mito, Naoko Arata, Yukihiro Ohya

Objective: To quantify the association between a combination of modifiable prepregnancy lifestyle factors and the risk of adverse pregnancy outcomes (APOs).

Design: Prospective cohort study.

Setting: The Japan Environment and Children's Study.

Population: A total of 79 703 pregnant Japanese women without chronic disease.

Methods: Maternal lifestyle before pregnancy was assessed using a self-administered questionnaire. A healthy lifestyle score (HLS, 0-5 points) was calculated based on adherence to five prepregnancy healthy lifestyle factors: healthy weight, high-quality diet, regular physical activity, not smoking, and not drinking alcohol. Relative risks (RRs) and 95% credible intervals (CrIs) were estimated using a Bayesian log-binomial regression model.

Main outcome measures: Composite APOs, defined as the development of any APO, including gestational diabetes, hypertensive disorders of pregnancy, preterm birth, low birth weight, and small-for-gestational-age, transcribed from medical records.

Results: A total of 13 894 women (17.4%) experienced one or more APOs. HLS was inversely associated with the risk of APOs in a dose-response manner. Women with an HLS of 5 points had a 33% (RR 0.67; 95% CrI, 0.61-0.74) lower risk of APOs than those with the lowest HLS (0-1 points). The population attributable fraction of five healthy lifestyle factors was 10.3%. A 1-point increase of HLS could have reduced APO cases by 6.6%.

Conclusions: A higher HLS was associated with a lower risk of APOs, suggesting that adopting a healthy lifestyle before pregnancy may reduce the risk of APOs, which can increase the risk of future chronic diseases in both mother and child.

摘要量化可改变的孕前生活方式因素组合与不良妊娠结局(APOs)风险之间的关联:前瞻性队列研究:环境:日本环境与儿童研究:方法:通过对孕前生活方式进行评估,确定孕前生活方式与不良妊娠结局(APOs)之间的关系:方法:采用自填式问卷对孕产妇怀孕前的生活方式进行评估。根据孕前五项健康生活方式因素(健康体重、优质饮食、规律运动、不吸烟、不饮酒)的坚持情况计算出健康生活方式得分(HLS,0-5 分)。采用贝叶斯对数二叉回归模型估算相对风险(RRs)和 95% 可信区间(CrIs):主要结果测量指标:根据医疗记录转录的复合 APOs,定义为任何 APO 的发生,包括妊娠糖尿病、妊娠高血压疾病、早产、低出生体重和小于胎龄:共有 13 894 名妇女(17.4%)经历过一次或多次妊娠高血压。HLS与发生APO的风险呈剂量反应式的反比关系。健康生活方式指数为 5 分的妇女比健康生活方式指数最低(0-1 分)的妇女发生 APO 的风险低 33% (RR 0.67; 95% CrI, 0.61-0.74)。五项健康生活方式因素的人群可归因比例为 10.3%。结论:健康生活方式指数每增加1分,APO病例就会减少6.6%:结论:较高的健康生活方式指数与较低的 APO 风险相关,这表明在怀孕前采取健康的生活方式可降低 APO 风险,而 APO 可增加母婴未来罹患慢性疾病的风险。
{"title":"Adherence to Healthy Prepregnancy Lifestyle and Risk of Adverse Pregnancy Outcomes: A Prospective Cohort Study.","authors":"Hitomi Okubo, Shoji F Nakayama, Asako Mito, Naoko Arata, Yukihiro Ohya","doi":"10.1111/1471-0528.17994","DOIUrl":"https://doi.org/10.1111/1471-0528.17994","url":null,"abstract":"<p><strong>Objective: </strong>To quantify the association between a combination of modifiable prepregnancy lifestyle factors and the risk of adverse pregnancy outcomes (APOs).</p><p><strong>Design: </strong>Prospective cohort study.</p><p><strong>Setting: </strong>The Japan Environment and Children's Study.</p><p><strong>Population: </strong>A total of 79 703 pregnant Japanese women without chronic disease.</p><p><strong>Methods: </strong>Maternal lifestyle before pregnancy was assessed using a self-administered questionnaire. A healthy lifestyle score (HLS, 0-5 points) was calculated based on adherence to five prepregnancy healthy lifestyle factors: healthy weight, high-quality diet, regular physical activity, not smoking, and not drinking alcohol. Relative risks (RRs) and 95% credible intervals (CrIs) were estimated using a Bayesian log-binomial regression model.</p><p><strong>Main outcome measures: </strong>Composite APOs, defined as the development of any APO, including gestational diabetes, hypertensive disorders of pregnancy, preterm birth, low birth weight, and small-for-gestational-age, transcribed from medical records.</p><p><strong>Results: </strong>A total of 13 894 women (17.4%) experienced one or more APOs. HLS was inversely associated with the risk of APOs in a dose-response manner. Women with an HLS of 5 points had a 33% (RR 0.67; 95% CrI, 0.61-0.74) lower risk of APOs than those with the lowest HLS (0-1 points). The population attributable fraction of five healthy lifestyle factors was 10.3%. A 1-point increase of HLS could have reduced APO cases by 6.6%.</p><p><strong>Conclusions: </strong>A higher HLS was associated with a lower risk of APOs, suggesting that adopting a healthy lifestyle before pregnancy may reduce the risk of APOs, which can increase the risk of future chronic diseases in both mother and child.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra- and Postoperative Complications in 4565 vNOTES Hysterectomies: International Registry Cohort Study. 4565例vNOTES子宫切除术的术中和术后并发症:国际注册队列研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-18 DOI: 10.1111/1471-0528.18000
Andrea Stuart, Johanna Wagenius, Levon Badiglian-Filho, Jens Schnabel, Alvaro Montealegre, Sophia Ehrström, Michael Hartmann, Jona Vercammen, Daniela Huber, Anna Lingström, Jan Baekelandt

Objective: To present the rates of intra- and postoperative complications and conversions in a large cohort of unselected vNOTES hysterectomies, performed by surgeons with different levels of expertise.

Design: International register-based cohort study.

Setting: Hysterectomies in the iNOTESs registry, 2015 to January 2024, performed by 201 surgeons from multiple countries.

Population: 4565 patients undergoing vNOTES hysterectomy.

Methods: Descriptive data are presented in frequencies (n) and percent (%).

Main outcome measure: Intra- and postoperative complications. Conversions.

Results: Intraoperative and postoperative complication rates were 3.2% (n = 144) and 2.5% (n = 115), respectively. Conversions occurred in 1.6% (n = 72), of which 10 (0.2%) to laparotomy, and 82% of the conversions occurred within the first 50 cases of the surgeon's learning curve. The most common intraoperative complication was cystotomy, occurring in 1.3%, and almost half were performed by inexperienced surgeons. Other intraoperative organ injuries occurred in 20 cases (0.44%). Postoperatively, the most common complications were haemorrhage (n = 28), vault complications (n = 26) including 11 infected vault hematomas, cystitis (n = 18) and non-specific infections (n = 14). The vNOTES hysterectomies were performed by 201 surgeons, of which 9.5% had performed more than 50 vNOTES cases, representing 70% of the registered cases in the registry. The remaining 30% of the hysterectomies mainly represent learning curve data from 90% of the included surgeons. The complication rate decreased with increasing surgical experience.

Conclusions: The largest study population of vNOTES hysterectomies is presented, including both learning curve data and data from experienced surgeons, with acceptable rates of intra- and postoperative complications. No implication was found of vNOTES being inferior to other minimally invasive methods.

目的介绍由不同专业水平的外科医生实施的大量未经选择的vNOTES子宫切除术的术中、术后并发症和转归发生率:设计:基于国际登记的队列研究:2015年至2024年1月iNOTESs登记册中的子宫切除术,由来自多个国家的201名外科医生实施:4565名接受vNOTES子宫切除术的患者:主要结果指标:术中和术后并发症。结果:术中和术后并发症术中和术后并发症发生率分别为 3.2%(n = 144)和 2.5%(n = 115)。1.6%(n = 72)的患者转为开腹手术,其中10例(0.2%)转为开腹手术,82%的转腹手术发生在外科医生学习曲线的前50个病例中。最常见的术中并发症是膀胱切开术,发生率为1.3%,其中近一半是由缺乏经验的外科医生实施的。其他术中器官损伤有 20 例(0.44%)。术后最常见的并发症是出血(28 例)、穹隆并发症(26 例),包括 11 例感染性穹隆血肿、膀胱炎(18 例)和非特异性感染(14 例)。vNOTES子宫切除术由201名外科医生实施,其中9.5%的外科医生实施过50例以上的vNOTES病例,占登记病例的70%。其余30%的子宫切除术主要代表了90%的外科医生的学习曲线数据。并发症发生率随着手术经验的增加而降低:结论:这是vNOTES子宫切除术的最大研究群体,包括学习曲线数据和经验丰富的外科医生的数据,术中和术后并发症发生率均可接受。没有发现 vNOTES 不如其他微创方法的暗示。
{"title":"Intra- and Postoperative Complications in 4565 vNOTES Hysterectomies: International Registry Cohort Study.","authors":"Andrea Stuart, Johanna Wagenius, Levon Badiglian-Filho, Jens Schnabel, Alvaro Montealegre, Sophia Ehrström, Michael Hartmann, Jona Vercammen, Daniela Huber, Anna Lingström, Jan Baekelandt","doi":"10.1111/1471-0528.18000","DOIUrl":"https://doi.org/10.1111/1471-0528.18000","url":null,"abstract":"<p><strong>Objective: </strong>To present the rates of intra- and postoperative complications and conversions in a large cohort of unselected vNOTES hysterectomies, performed by surgeons with different levels of expertise.</p><p><strong>Design: </strong>International register-based cohort study.</p><p><strong>Setting: </strong>Hysterectomies in the iNOTESs registry, 2015 to January 2024, performed by 201 surgeons from multiple countries.</p><p><strong>Population: </strong>4565 patients undergoing vNOTES hysterectomy.</p><p><strong>Methods: </strong>Descriptive data are presented in frequencies (n) and percent (%).</p><p><strong>Main outcome measure: </strong>Intra- and postoperative complications. Conversions.</p><p><strong>Results: </strong>Intraoperative and postoperative complication rates were 3.2% (n = 144) and 2.5% (n = 115), respectively. Conversions occurred in 1.6% (n = 72), of which 10 (0.2%) to laparotomy, and 82% of the conversions occurred within the first 50 cases of the surgeon's learning curve. The most common intraoperative complication was cystotomy, occurring in 1.3%, and almost half were performed by inexperienced surgeons. Other intraoperative organ injuries occurred in 20 cases (0.44%). Postoperatively, the most common complications were haemorrhage (n = 28), vault complications (n = 26) including 11 infected vault hematomas, cystitis (n = 18) and non-specific infections (n = 14). The vNOTES hysterectomies were performed by 201 surgeons, of which 9.5% had performed more than 50 vNOTES cases, representing 70% of the registered cases in the registry. The remaining 30% of the hysterectomies mainly represent learning curve data from 90% of the included surgeons. The complication rate decreased with increasing surgical experience.</p><p><strong>Conclusions: </strong>The largest study population of vNOTES hysterectomies is presented, including both learning curve data and data from experienced surgeons, with acceptable rates of intra- and postoperative complications. No implication was found of vNOTES being inferior to other minimally invasive methods.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Reply. 作者回复。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-15 DOI: 10.1111/1471-0528.18001
Martin C S Wong, Man Kin Yim, Claire Chenwen Zhong, Junjie Huang
{"title":"Author Reply.","authors":"Martin C S Wong, Man Kin Yim, Claire Chenwen Zhong, Junjie Huang","doi":"10.1111/1471-0528.18001","DOIUrl":"https://doi.org/10.1111/1471-0528.18001","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Reply. 作者回复。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-13 DOI: 10.1111/1471-0528.18002
Jing Zhu, Yuexin Gan, Cuiping Yang, Wei Gu, Yanlin Wang, Jun Zhang, Zhiwei Liu
{"title":"Author Reply.","authors":"Jing Zhu, Yuexin Gan, Cuiping Yang, Wei Gu, Yanlin Wang, Jun Zhang, Zhiwei Liu","doi":"10.1111/1471-0528.18002","DOIUrl":"https://doi.org/10.1111/1471-0528.18002","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Reply. 作者回复。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-12 DOI: 10.1111/1471-0528.18003
Camilla T Mentzoni, Kari Klungsøyr, Hilde M Engjom
{"title":"Author Reply.","authors":"Camilla T Mentzoni, Kari Klungsøyr, Hilde M Engjom","doi":"10.1111/1471-0528.18003","DOIUrl":"https://doi.org/10.1111/1471-0528.18003","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimising Anti-D Use: Revisiting Guidelines for First Trimester Abortions. 优化抗 D 药物的使用:重新审视第一胎流产指南。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-07 DOI: 10.1111/1471-0528.17996
Katherine C Whitehouse, Patricia A Lohr, John Reynolds-Wright, Jonathan Lord, Stephen Robson, Tracey Masters, Yvonne Neubauer, Lydia Kingsley, Sharon Cameron
{"title":"Optimising Anti-D Use: Revisiting Guidelines for First Trimester Abortions.","authors":"Katherine C Whitehouse, Patricia A Lohr, John Reynolds-Wright, Jonathan Lord, Stephen Robson, Tracey Masters, Yvonne Neubauer, Lydia Kingsley, Sharon Cameron","doi":"10.1111/1471-0528.17996","DOIUrl":"https://doi.org/10.1111/1471-0528.17996","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome Reporting in Studies Investigating Treatment for Caesarean Scar Ectopic Pregnancy: A Systematic Review. 剖腹产瘢痕宫外孕治疗研究的结果报告:系统回顾。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-07 DOI: 10.1111/1471-0528.17989
Simrit Nijjar, Simarjit Sandhar, Ilan E Timor-Tritsch, Andrea Kaelin Agten, Jin Li, Krystle Y Chong, Munira Oza, Rosanna Acklom, Francesco D'Antonio, Lan N Vuong, Ben Mol, Cecilia Bottomley, Davor Jurkovic

Background: Caesarean scar ectopic pregnancy (CSEP) is associated with significant maternal and foetal morbidity. However, the optimal treatment remains unknown.

Objectives: The aim of this study was to review outcomes reported in studies on CSEP treatment and outcome reporting quality.

Search strategy: We reviewed 1270 articles identified through searching PubMed, MEDLINE and Google Scholar from 2014 to 2024 using the search terms 'caesarean scar ectopic pregnancy and caesarean scar pregnancy'.

Selection criteria: We included all study types evaluating any form of CSEP treatment, with a sample size of ≥ 50, where diagnosis was described, and the article was in English.

Data collection and analysis: Two authors independently reviewed studies and assessed outcome reporting and methodological quality. The relationship between outcome reporting quality and publication year and journal type was assessed with univariate and bivariate models.

Main results: A total of 108 studies, including 17 941 women, were included. 83% of all studies originated from China. Studies reported on 326 outcomes; blood loss (86%), need for additional intervention (77%) and time for serum hCG to normalise post treatment (69%) were the most common outcomes. A primary outcome was clearly defined in 11 (10%) studies. The median quality of outcome reporting was 3 (IQR 3-4). No relationship was demonstrated between outcome reporting quality and publication year (p = 0.116) or journal type (p = 0.503).

Conclusions: This review demonstrates that there is a wide variation in outcomes reported in studies on CSEP treatment. Development and implementation of a core outcome set by international stakeholders which includes patients is urgently needed to enable high-quality research that is both useful and relevant to patients.

背景:剖腹产瘢痕异位妊娠(CSEP)与严重的母体和胎儿发病率有关。然而,最佳治疗方法仍然未知:本研究旨在回顾CSEP治疗研究中报告的结果以及结果报告的质量:检索词为 "剖腹产瘢痕异位妊娠和剖腹产瘢痕妊娠",通过检索 PubMed、MEDLINE 和 Google Scholar(2014 年至 2024 年),我们查阅了 1270 篇文章:我们纳入了所有评估任何形式CSEP治疗的研究类型,样本量≥50,其中描述了诊断,文章为英文:两位作者独立审阅研究,评估结果报告和方法质量。采用单变量和双变量模型评估结果报告质量与发表年份和期刊类型之间的关系:主要结果:共纳入 108 项研究,包括 17 941 名女性。83%的研究来自中国。研究报告了 326 项结果;失血(86%)、需要额外干预(77%)和治疗后血清 hCG 恢复正常的时间(69%)是最常见的结果。有 11 项(10%)研究明确定义了主要结果。结果报告质量的中位数为 3(IQR 3-4)。结果报告质量与发表年份(p = 0.116)或期刊类型(p = 0.503)之间没有关系:本综述表明,CSEP 治疗研究中报告的结果差异很大。国际利益相关者急需制定并实施一套包括患者在内的核心结果,以便开展对患者有用且相关的高质量研究。
{"title":"Outcome Reporting in Studies Investigating Treatment for Caesarean Scar Ectopic Pregnancy: A Systematic Review.","authors":"Simrit Nijjar, Simarjit Sandhar, Ilan E Timor-Tritsch, Andrea Kaelin Agten, Jin Li, Krystle Y Chong, Munira Oza, Rosanna Acklom, Francesco D'Antonio, Lan N Vuong, Ben Mol, Cecilia Bottomley, Davor Jurkovic","doi":"10.1111/1471-0528.17989","DOIUrl":"10.1111/1471-0528.17989","url":null,"abstract":"<p><strong>Background: </strong>Caesarean scar ectopic pregnancy (CSEP) is associated with significant maternal and foetal morbidity. However, the optimal treatment remains unknown.</p><p><strong>Objectives: </strong>The aim of this study was to review outcomes reported in studies on CSEP treatment and outcome reporting quality.</p><p><strong>Search strategy: </strong>We reviewed 1270 articles identified through searching PubMed, MEDLINE and Google Scholar from 2014 to 2024 using the search terms 'caesarean scar ectopic pregnancy and caesarean scar pregnancy'.</p><p><strong>Selection criteria: </strong>We included all study types evaluating any form of CSEP treatment, with a sample size of ≥ 50, where diagnosis was described, and the article was in English.</p><p><strong>Data collection and analysis: </strong>Two authors independently reviewed studies and assessed outcome reporting and methodological quality. The relationship between outcome reporting quality and publication year and journal type was assessed with univariate and bivariate models.</p><p><strong>Main results: </strong>A total of 108 studies, including 17 941 women, were included. 83% of all studies originated from China. Studies reported on 326 outcomes; blood loss (86%), need for additional intervention (77%) and time for serum hCG to normalise post treatment (69%) were the most common outcomes. A primary outcome was clearly defined in 11 (10%) studies. The median quality of outcome reporting was 3 (IQR 3-4). No relationship was demonstrated between outcome reporting quality and publication year (p = 0.116) or journal type (p = 0.503).</p><p><strong>Conclusions: </strong>This review demonstrates that there is a wide variation in outcomes reported in studies on CSEP treatment. Development and implementation of a core outcome set by international stakeholders which includes patients is urgently needed to enable high-quality research that is both useful and relevant to patients.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bjog-An International Journal of Obstetrics and Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1